These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 25493552)
1. Proactive case finding to improve concurrently curative and palliative care in patients with end-stage liver disease. Walling AM; Schreibeis-Baum H; Pimstone N; Asch SM; Robinson L; Korlekar S; Lorenz K; Nwajuaku T; Rosenfeld K J Palliat Med; 2015 Apr; 18(4):378-81. PubMed ID: 25493552 [TBL] [Abstract][Full Text] [Related]
2. Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease. Patel A; Asch S; Antonio AL; Kanwal F; Lorenz K; Riopelle D; Dickey A; Larkin J; Lee M; Walling A Dig Dis Sci; 2020 Sep; 65(9):2562-2570. PubMed ID: 31927765 [TBL] [Abstract][Full Text] [Related]
3. The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review. Kelly SG; Campbell TC; Hillman L; Said A; Lucey MR; Agarwal PD Ann Hepatol; 2017; 16(3):395-401. PubMed ID: 28425409 [TBL] [Abstract][Full Text] [Related]
4. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U; J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408 [TBL] [Abstract][Full Text] [Related]
5. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma. Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099 [TBL] [Abstract][Full Text] [Related]
7. Palliative care in end-stage liver disease: Time to do better? Mazzarelli C; Prentice WM; Heneghan MA; Belli LS; Agarwal K; Cannon MD Liver Transpl; 2018 Jul; 24(7):961-968. PubMed ID: 29729119 [TBL] [Abstract][Full Text] [Related]
8. Integration of palliative care in end-stage liver disease and liver transplantation. Potosek J; Curry M; Buss M; Chittenden E J Palliat Med; 2014 Nov; 17(11):1271-7. PubMed ID: 25390468 [TBL] [Abstract][Full Text] [Related]
9. Palliative care in patients with liver cirrhosis: it is the time to deal with the burden. Lisotti A; Fusaroli P; Caletti G BMJ Support Palliat Care; 2015 Dec; 5(5):466-7. PubMed ID: 26124513 [No Abstract] [Full Text] [Related]
10. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006 [TBL] [Abstract][Full Text] [Related]
11. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list. Toso C; Majno P; Berney T; Morel P; Mentha G; Combescure C Transpl Int; 2014 Jul; 27(7):686-95. PubMed ID: 24649861 [TBL] [Abstract][Full Text] [Related]
12. Attributes and outcomes of end stage liver disease as compared with other noncancer patients admitted to a geriatric palliative care unit. Perri GA; Bunn S; Oh YJ; Kassam A; Berall A; Karuza J; Khosravani H Ann Palliat Med; 2016 Apr; 5(2):76-82. PubMed ID: 27121735 [TBL] [Abstract][Full Text] [Related]
13. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM; Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643 [TBL] [Abstract][Full Text] [Related]
14. VA Palliative Care: The Filling and Relaxing of Diastole. Levy CR J Palliat Med; 2015 Oct; 18(10):818-9. PubMed ID: 26439727 [No Abstract] [Full Text] [Related]
15. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease. Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365 [TBL] [Abstract][Full Text] [Related]
17. Inpatient Specialty-Level Palliative Care Is Delivered Late in the Course of Hepatocellular Carcinoma and Associated With Lower Hazard of Hospital Readmission. Woodrell CD; Goldstein NE; Moreno JR; Schiano TD; Schwartz ME; Garrido MM J Pain Symptom Manage; 2021 May; 61(5):940-947.e3. PubMed ID: 33035651 [TBL] [Abstract][Full Text] [Related]
18. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732 [TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Yao FY; Bass NM; Ascher NL; Roberts JP Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253 [TBL] [Abstract][Full Text] [Related]
20. Liver transplantation: from Child to MELD. Gallegos-Orozco JF; Vargas HE Med Clin North Am; 2009 Jul; 93(4):931-50, ix. PubMed ID: 19577123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]